HSBC Holdings
NVO

HSBC Holdings’s Novo Nordisk NVO Stock Holding History

HSBC Holdings’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.15M Sell
170,000
-108,300
-39% -$4.65M ﹤0.01% 1035
2026
Q1 		$10.2M Sell
278,300
-237,500
-46% -$11.3M 0.01% 928
2025
Q4 		$26.3M Buy
515,800
+374,400
+265% +$19.1M 0.01% 665
2025
Q3 		$7.84M Sell
141,400
-173,400
-55% -$10.1M ﹤0.01% 1019
2025
Q2 		$21.9M Hold
314,800
– – 0.01% 676
2025
Q1 		$21.9M Buy
314,800
+269,700
+598% +$22.3M 0.01% 682
2024
Q4 		$3.87M Buy
+45,100
New +$4.88M ﹤0.01% 1226

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

HSBC Holdings's NVO Position: Q2 2026 in Review

HSBC Holdings reduced its Novo Nordisk (NVO) stake by 42% in Q2 2026, selling an estimated $16.1M and leaving 524,829 shares worth $25.2M. The position accounts for 0.01% of the portfolio, ranked #693.

HSBC Holdings first reported a position in NVO in Q3 2014 and has held it in 48 quarters since. The position peaked at $55M in Q2 2023. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • HSBC Holdings held 524,829 shares of Novo Nordisk worth $25.2M as of Q2 2026.
  • HSBC Holdings sold 374,975 Novo Nordisk shares in Q2 2026, an estimated $16.1M.
  • Novo Nordisk made up 0.01% of HSBC Holdings's portfolio in Q2 2026, its #693 holding.
  • HSBC Holdings first reported a position in Novo Nordisk in Q3 2014 and has held it in 48 quarters since.
  • HSBC Holdings's Novo Nordisk position peaked at $55M in Q2 2023.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.